Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Vircell AMPLIRUN® TOTAL Monkeypox Virus Control

New AMPLIRUN TOTAL that contains inactivated Monkeypox virus (MPXV) formulated in viral transport medium intended to validate and control sample processing, amplification, and detection in nucleic acid assays as a 3rd party control.

Product details

Code: VCMBTC032R

Description: AMPLIRUN® TOTAL MONKEYPOX VIRUS CONTROL (SWAB)

Available for Research Use Only in Australia.


Kit Contents

10 vials with lyophilized Monkeypox virus (10,000-25,000 copies/vial).

  • Batch concentration is provided in the certificate of analysis
  • The quantification is performed by real-time PCR
  • Reconstitution volume: 500 µl

Origin

From purified viral particles obtained in VERO E6 cells. Viruses are inactivated, rendering them non-infectious, and diluted in transport medium containing cells obtained from epithelial human cell lines.

Complete sequence available at www.vircell.com.


Storage Requirements and Shelf life

  • No special transport conditions are required
  • The vials are to be kept lyophilized at 2-8ºC. After reconstitution, suspension should be used on the same day. Unused product should be discarded
  • AMPLIRUN TOTAL Controls have a shelf life of 30 months from the date of manufacture

AMPLIRUN TOTAL Monkeypox Virus Control Flyer

Download here >

Request Insert Sheet

Click here >

View AMPLIRUN Total Catalogue

Download Catalogue >

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article